AI & Data Science
Biomedical analytics, predictive modeling, and intelligent research workflows.
Oncology • Biotechnology • Precision Medicine
Advancing Oncology
Survival Analytics
for Precision Medicine
Delivering specialized oncology survival analytics, scientific consulting, and translational research solutions built on deep biomedical and quantitative expertise.
First launch may take up to 60 seconds while the application wakes up.
Grant & Publication Strategy
From Idea to Publication
Strengthen your research strategy, preliminary data, and study design to support competitive grant applications and high-impact publications.
Study Design
Data Analysis
Survival Analysis
Publication Support
Stuck on a research problem? Our goal is to help you overcome key bottlenecks and achieve meaningful, publishable progress within 3–6 months.
Accelerate Your Research基金申请与论文策略
从科研构想到论文发表
强化研究策略、预实验数据和课题设计，助力更具竞争力的基金申请与高水平论文发表。
课题设计
数据分析
生存分析
论文支持
课题遇到瓶颈？我们的目标是在 3–6 个月内帮助您突破关键难点，推动项目取得具有实质意义、可发表的研究进展。
科研助力About GenMabs
Scientific depth. Forward-looking innovation.
Founded2018Georgia, United States
Our Story
Founded in 2018, GenMabs LLC is a biotechnology company headquartered in Georgia, United States. Since its establishment, the company has been committed to advancing biomedical innovation through scientific research, data science, and emerging technologies. Today, GenMabs integrates artificial intelligence with precision medicine to develop practical solutions that support biomedical research, clinical decision-support, and healthcare innovation.
Looking Ahead
GenMabs will continue expanding its work across artificial intelligence, precision medicine, scientific consulting, biomedical research, and translational medicine, with the goal of accelerating the transformation of scientific discoveries into real-world healthcare innovations. Our long-term vision is to bridge rigorous research and meaningful healthcare impact through responsible technologies, strong evidence, and collaborative partnerships.
Our Focus
A platform for long-term biotechnology growth
Precision Medicine
Tools that help translate patient and cohort data into actionable scientific insight.
Scientific Consulting
Research strategy, experimental design, biomedical analytics, and translational planning.
Explore consulting →Biotechnology Innovation
Long-term opportunities in diagnostics, biomarkers, therapeutic antibodies, and research products.
Featured Product
Now Available
OncoAI™
AI-Powered Cancer Survival Prediction Platform
OncoAI is our first-generation clinical AI platform designed to support researchers and healthcare professionals in analyzing cancer survival risk using statistical modeling, machine learning, and cohort-level analytics.
Individual prediction
Batch prediction
Survival analysis
Risk stratification
Export-ready cohort reports
Technology
Where AI meets biotechnology
Artificial Intelligence
Machine learning, statistical modeling, and intelligent software for biomedical data interpretation.
Clinical Data Science
Risk modeling, survival analysis, cohort analytics, and decision-support workflows.
Biotechnology R&D
Future programs in therapeutic antibodies, biomarker discovery, diagnostics, and AI-assisted drug discovery.
Pipeline
Software today. Broader biomedical innovation tomorrow.
Current
OncoAI™
Clinical AI platform for cancer survival prediction and cohort analytics.
In Development
TumorGPT™
AI assistant concept for oncology research, biomedical interpretation, and precision medicine workflows.
Now Available
Scientific Research Consulting
Integrated support in research strategy, experimental design, biostatistics, biomedical data science, and AI-driven research.
Future Programs
Broader Biomedical Innovation
Potential programs in diagnostics, therapeutic antibodies, biomarkers, research products, and AI-assisted drug discovery.
Responsible Innovation
GenMabs develops research and decision-support technologies. OncoAI outputs are intended for research, evaluation, and decision-support contexts and should not be used as the sole basis for diagnosis, treatment, or other direct clinical decisions.
Contact
GenMabs LLC
Biotechnology company founded in 2018 and based in Georgia, United States.
Scientific Consulting
Need a stronger research direction, study design, or analysis plan?
GenMabs provides integrated consulting in research strategy, experimental design, biostatistics, survival analysis, TCGA/GDC data science, and AI-driven biomedical research.
Collaboration
Interested in partnering with GenMabs?
Learn about complimentary product training, professional materials, live demonstrations, technical support, referral rewards, and opportunities for long-term scientific collaboration.